Patient Assessment & Care Planning Flashcards
7 cards from real MTM practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 Patient Assessment & Care Planning flashcards as text
A pharmacist is assessing a patient with heart failure who is taking an NSAID for arthritis pain. What is the primary concern in the care planning process?
Answer: NSAIDs reduce the efficacy of ACE inhibitors and promote sodium retention, worsening heart failure
NSAIDs antagonize the effects of ACE inhibitors/diuretics and promote fluid retention, exacerbating heart failure symptoms.
When prioritizing drug therapy problems in a care plan, which factor should be given the highest weight?
Answer: Severity and immediacy of harm to the patient
Drug therapy problems should be prioritized based on the potential severity of harm and how urgently intervention is needed.
Which of the following is an example of a SMART goal in an MTM care plan?
Answer: Patient will achieve systolic BP below 130 mmHg within 4 weeks
SMART goals are Specific, Measurable, Achievable, Relevant, and Time-bound; a target BP with a defined timeframe meets all criteria.
A pharmacist discovers a patient is taking two different statins simultaneously (atorvastatin and rosuvastatin prescribed by two different providers). Which drug therapy problem category applies?
Answer: Unnecessary drug therapy — duplicate therapy
Duplicate therapy occurs when two drugs from the same class are prescribed concurrently without clinical rationale, constituting unnecessary therapy.
During a patient assessment, the pharmacist notes the patient has difficulty opening child-proof caps. How should this be addressed in the care plan?
Answer: Document as a barrier to adherence and recommend easy-open caps or blister packs
Physical barriers to adherence such as difficulty opening containers should be documented and addressed with practical solutions like easy-open caps.
A patient with atrial fibrillation and a CHA₂DS₂-VASc score of 4 is not on anticoagulation. Which drug therapy problem does this represent?
Answer: Needs additional drug therapy
A CHA₂DS₂-VASc score of 4 indicates high stroke risk, and the absence of anticoagulation represents a need for additional drug therapy.
Which statement best describes the pharmacist's role in collaborative care planning for MTM patients?
Answer: The pharmacist identifies drug therapy problems and communicates recommendations to prescribers while engaging patients in self-management
MTM pharmacists identify and resolve drug therapy problems through collaboration with prescribers and patient education, not independent prescribing.